Baptist Health Foundation Receives $2M Gift to Establish Endowed Chair at Baptist Health Miami Neuroscience Institute - Summary - MDSpire

Baptist Health Foundation Receives $2M Gift to Establish Endowed Chair at Baptist Health Miami Neuroscience Institute

Baptist Health Foundation announced that it has received a $2 million donation from Anthony and Joyce Esernia to establish a new endowed chair at Baptist Health Miami Neuroscience Institute.

  • By

  • May 1, 2026

  • 5 min

Share

Objective:

To establish the Esernia Endowed Chair in Surgical Treatment of Adult Epilepsy and Movement Disorders at Baptist Health Miami Neuroscience Institute, enhancing its capacity for innovative research and patient care.

Key Findings:
  • Dr. Aviva Abosch is a recognized expert in functional neurosurgery and deep brain stimulation.
  • Movement disorders and epilepsy significantly impact quality of life for patients.
  • The Miami Neuroscience Institute is developing a prominent program in functional neurosurgery.
  • The endowed chair is expected to lead to improved treatment options and outcomes for patients.
Interpretation:

The establishment of the endowed chair is expected to enhance research and treatment options for patients with epilepsy and movement disorders, addressing a critical healthcare need.

Limitations:
  • The article does not provide specific details on the expected outcomes of the research funded by the endowed chair, such as metrics for success.
  • No information on the timeline for the implementation of new therapies or clinical trials is provided.
Conclusion:

The Esernia Endowed Chair will play a crucial role in advancing innovative treatments for epilepsy and movement disorders, benefiting patients and families, and addressing a critical healthcare need.

Original Source(s)

Baptist Health Foundation Receives $2M Gift to Establish Endowed Chair at Baptist Health Miami Neuroscience Institute

  • by

  • May 1, 2026

Related Content

Baptist Health Miami Neuroscience Institute Advances Parkinson’s Disease Imaging With Specialized MRI Protocol

Diagnosing Parkinson’s disease has long depended primarily on clinical expertise — careful neurologic examination, longitudinal symptom assessment and the nuanced interpretation of movement abnormalities.

  • by

  • May 11, 2026

  • 5 min
Parkinson's Aggravated by Nanoplastics Exposure

Mouse study suggests environmental nanoplastics may exacerbate Parkinson's disease through metabolic dysregulation in the gut, brain, and liver

Lorazepam-induced full resolution of catatonia and psychosis in Parkinson’s disease with acromegaly: a case report